Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
Avidity Biosciences (RNA) Ownership - Who Owns Avidity Biosciences?
540 Followers
Avidity Biosciences (RNA) Ownership Overview
11.78% Insiders
24.29% Mutual Funds
14.13% Other Institutional Investors
49.80% Public Companies and Individual Investors
The ownership structure of Avidity Biosciences (RNA) stock is a mix of institutional, retail and individual investors. Approximately 38.42% of the company’s stock is owned by Institutional Investors, 11.78% is owned by Insiders and 49.80% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 03, 2024 | Sarah Boyce President & Ceo,director | xxxxxxxxxxxxx | $734720 |
| Apr 03, 2024 | Arthur Levin Director | xxxxxxxxxxxxx | $542200 |
| Mar 21, 2024 | Arthur Levin Director | xxxxxxxxxxxxx | $119800 |
| Mar 15, 2024 | xxxxxxxxxxxxx | $980400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $110450 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $14963345 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $15466676 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $83761233 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,442,863 | Institution | 5.69% | 245,581,979 | |
| 4,557,112 | Institution | 4.77% | 205,616,893 | |
| 3,624,789 | Institution | 3.79% | 163,550,480 | |
| 3,620,888 | Institution | 3.79% | 163,374,467 | |
| 3,282,180 | Institution | 3.43% | 148,091,962 | |
| 3,072,916 | Institution | 3.21% | 138,649,970 | |
| 2,168,441 | Institution | 2.27% | 97,840,058 | |
| 1,457,894 | Institution | 1.52% | 65,780,177 | |
| 1,304,873 | Institution | 1.36% | 58,875,870 | |
| 1,282,164 | Institution | 1.34% | 57,851,240 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,624,789 | Institution | 3.79% | 163,550,480 | |
| 3,620,888 | Institution | 3.79% | 163,374,467 | |
| 3,072,916 | Institution | 3.21% | 138,649,970 | |
| 2,168,441 | Institution | 2.27% | 97,840,058 | |
| 1,457,894 | Institution | 1.52% | 65,780,177 | |
| 1,282,164 | Institution | 1.34% | 57,851,240 | |
| 799,592 | Institution | 0.84% | 36,077,591 | |
| 728,316 | Institution | 0.76% | 32,861,618 | |
| 680,531 | Institution | 0.71% | 30,705,559 | |
| 650,000 | Institution | 0.68% | 29,328,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,185,958 | Institution | 3.33% | 130,146,384 | |
| 2,685,126 | Institution | 2.81% | 121,152,885 | |
| 1,466,191 | Institution | 1.53% | 59,893,902 | |
| 1,123,563 | Institution | 1.17% | 50,301,916 | |
| 906,005 | Institution | 0.95% | 40,878,946 | |
| 627,681 | Institution | 0.66% | 28,320,967 | |
| 457,874 | Institution | 0.48% | 20,499,019 | |
| 376,300 | Institution | 0.39% | 15,371,855 | |
| 265,959 | Institution | 0.28% | 10,864,425 | |
| 191,966 | Institution | 0.20% | 8,661,506 |
FAQ
Who Owns Avidity Biosciences Inc (RNA)?
According to the latest TipRanks data, approximately 14.13% of the company's stock is held by institutional investors, 11.78% is held by insiders, and 49.80% is held by retail investors.
What percentage of Avidity Biosciences Inc (RNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.13% of Avidity Biosciences Inc (RNA) stock is held by institutional investors.
What percentage of Avidity Biosciences Inc (RNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.80% of Avidity Biosciences Inc (RNA) stock is held by retail investors.
Who owns the most shares of Avidity Biosciences Inc (RNA)?
Vanguard owns the most shares of Avidity Biosciences Inc (RNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.